Compare · ACCD vs KBLM
ACCD vs KBLM
Side-by-side comparison of Accolade Inc. (ACCD) and KBL Merger Corp. IV (KBLM): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while KBLM operates in Finance - the two are in different parts of the market.
- ACCD carries a market cap of $1.18B.
- ACCD has more recent analyst coverage (25 ratings vs 0 for KBLM).
- Company
- Accolade Inc.
- KBL Merger Corp. IV
- Price
- $7.03+0.00%
- -
- Market cap
- $1.18B
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2017
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 0
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest KBLM
- KBL Merger Corp. IV Announces Completion of Acquisition of 180 Life Sciences Corp. and Trading Under the ticker ATNF Starting November 9, 2020
- KBL Merger Corp. IV Announces Approval of Business Combination with 180 Life Sciences at the Special Meeting of Shareholders Held on November 5, 2020
- KBL Merger Corp. IV Announces Change of Special Meeting of Shareholders Date to November 5, 2020
- Innovative Companies with Blockbuster Potential Catch SPAC Attention
- In Pursuit of the Elusive Drug -- the Billion-Dollar Blockbuster
- UPDATE -- The Quest for Blockbuster Drugs Continues
- Blockbuster Year and Bright Horizons for SPACs
- Life-Saving Advancements, Treatments Delivered by Companies Invested in Innovation
- Groundbreaking Studies Offer Hope for Unmet Medical Needs in Inflammatory Disease
- Solving One of the Largest Drivers of Disease: Inflammation